Valiant Laboratories Ltd 15 May 2024 12:00 AM
Valiant Laboratories reports consolidated net loss of Rs 1.24 crore in the March 2024 quarter,
Net loss of Valiant Laboratories reported to Rs 1.24 crore in the quarter ended March 2024 as against net profit of Rs 7.83 crore during the previous quarter ended March 2023. Sales declined 65.98% to Rs 30.59 crore in the quarter ended March 2024 as against Rs 89.92 crore during the previous quarter ended March 2023.For the full year,net profit declined 98.90% to Rs 0.32 crore in the year ended March 2024 as against Rs 29.00 crore during the previous year ended March 2023. Sales declined 45.48% to Rs 182.06 crore in the year ended March 2024 as against Rs 333.91 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales30.5989.92 -66 182.06333.91 -45 OPM %-14.819.59 --4.6210.51 - PBDT-2.0510.31 PL 1.2039.70 -97 PBT-2.579.87 PL -0.7738.14 PL NP-1.247.83 PL 0.3229.00 -99 Powered by Capital Market - Live News
Valiant Laboratories Ltd 07 May 2024 12:00 AM
Valiant Laboratories to hold board meeting,
Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 14 May 2024Powered by Capital Market - Live News
Valiant Laboratories Ltd 09 Feb 2024 12:00 AM
Valiant Laboratories reports standalone net loss of Rs 3.50 crore in the December 2023 quarter,
Net loss of Valiant Laboratories reported to Rs 3.50 crore in the quarter ended December 2023 as against net profit of Rs 7.65 crore during the previous quarter ended December 2022. Sales declined 42.74% to Rs 40.52 crore in the quarter ended December 2023 as against Rs 70.77 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales40.5270.77 -43 OPM %-15.6014.03 - PBDT-4.5610.67 PL PBT-5.0510.27 PL NP-3.507.65 PL Powered by Capital Market - Live News
Valiant Laboratories Ltd 02 Feb 2024 12:00 AM
Valiant Laboratories to convene board meeting,
Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 9 February 2024.Powered by Capital Market - Live News
Valiant Laboratories Ltd 07 Nov 2023 12:00 AM
Valiant Laboratories standalone net profit declines 90.88% in the September 2023 quarter,
Net profit of Valiant Laboratories declined 90.88% to Rs 0.79 crore in the quarter ended September 2023 as against Rs 8.66 crore during the previous quarter ended September 2022. Sales declined 32.30% to Rs 59.55 crore in the quarter ended September 2023 as against Rs 87.96 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales59.5587.96 -32 OPM %-2.3312.15 - PBDT1.5511.99 -87 PBT1.0611.62 -91 NP0.798.66 -91 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now